Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche and Athena See the Benefit of Clinical Lab Acquisitions

Executive Summary

Two drug companies, one large the other small, made acquisitions that highlight the role diagnostics will play in a more cost-constrained pharmaceutical environment. In Roche's acquiring National Health, it creates a player able to bundle drugs and diagnostic services together in attractively priced packages. Athena's acquisition of Genica, an esoteric testing lab specializing in CNS, boosts Athena's CNS sales force and gives the reps a series of technologically sophisticated products to sell to neurologists.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

IV000018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel